Authors: Zhang Hui, Zhang Xiaomin, Li Xiaorong DOI: 10.3760/cma.j.cn115989-20200424-00285 Published 2020-09-10 Cite as Chin J Exp Ophthalmol, 2020,38(09): 799-803. Abstract [View PDF] [Read Full Text] Exosomes are small extracellular vesicles secreted by cells and carry many biological molecules, such as mRNA, microRNA, proteins, and transcription […]
Category: Review
Application of machine learning in auxiliary diagnosis of corneal related diseases
Authors: Zhang Zijun, Liang Qingfeng DOI: 10.3760/cma.j.cn115989-20200201-00045 Published 2020-09-10 Cite as Chin J Exp Ophthalmol, 2020,38(09): 804-808. Abstract [View PDF] [Read Full Text] Machine learning, as the main technical direction of artificial intelligence, can help ophthalmologists to interpret and analyze the large amount of data […]
Application of single-cell RNA sequencing in visual system
Authors: Liu Yifan, Shen Yin DOI: 10.3760/cma.j.cn115989-20200509-00325 Published 2020-08-10 Cite as Chin J Exp Ophthalmol, 2020,38(08): 704-709. Abstract [View PDF] [Read Full Text] Single-cell RNA sequencing (scRNA-seq) is an emerging technology that observes transcriptomes’ differences between individual cells at the cellular level.The basic strategy is to […]
Review and analysis on knockout mouse models with cataract
Authors: Wu Zehua, Liu Xiangyuan, Li Yuying, Zhong Zilin, Chen Jianjun DOI: 10.3760/cma.j.cn115989-20190227-00087 Published 2020-08-10 Cite as Chin J Exp Ophthalmol, 2020,38(08): 710-714. Abstract [View PDF] [Read Full Text] Cataract is the leading cause of blindness worldwide, which is a generally clinical and genetic heterogeneity eye […]
Advances of genetics of age-related macular degeneration
Authors: Xu Jingjing, Hu Yuntao DOI: 10.3760/cma.j.cn115989-20200509-00324 Published 2020-08-10 Cite as Chin J Exp Ophthalmol, 2020,38(08): 715-720. Abstract [View PDF] [Read Full Text] Age-related macular degeneration (AMD) is one of the leading causes of blindness for the elderly over 50, characterized by loss of central vision […]
Research progress of survivin gene and eye diseases
Authors: Wang Xiaocong, Tan Wei DOI: 10.3760/cma.j.cn115989-20200509-00322 Published 2020-08-10 Cite as Chin J Exp Ophthalmol, 2020,38(08): 721-725. Abstract [View PDF] [Read Full Text] Survivin is a member of inhibitors of apoptosis protein family, compared with other members, survivin has a unique baculovirus apoptosis inhibitory protein—inhibitor of […]
Advances in genetic research of FOXL2 in patients with blepharophimosis-ptosis-epicanthus inversus syndrome
Authors: Yang Lin, Ke Min, Chen Xiaomin DOI: 10.3760/cma.j.cn115989-20200509-00323 Published 2020-08-10 Cite as Chin J Exp Ophthalmol, 2020,38(08): 726-728. Abstract [View PDF] [Read Full Text] Blepharophimosis-ptosis-epicanthus inversus syndrome (BPES) is a rare autosomal dominant disease, which has been divided into two types […]
Advances in animal models of retinal vein occlusion induced by laser photocoagulation and photodynamic therapy
Authors: Pei Chao, Feng Jun DOI: 10.3760/cma.j.cn115985-2019-0409-00174 Published 2020-07-10 Cite as Chin J Exp Ophthalmol, 2020,38(07): 621-624. Abstract [View PDF] [Read Full Text] Retinal vein occlusion (RVO) is a common retinal vascular disease that causes vision loss.The etiology of RVO is complex and its pathogenesis has […]
Predictive value of OCT parameters to prognosis of anti-VEGF therapy for macular edema secondary to retinal vein occlusion
Authors: Tang Fusheng, Lu Jianmin, Ma Xiang DOI: 10.3760/cma.j.cn115989-20200519-00358 Published 2020-07-10 Cite as Chin J Exp Ophthalmol, 2020,38(07): 625-628. Abstract [View PDF] [Read Full Text] Macular edema secondary to retinal vein occlusion (RVO) is the leading cause of visual impairment in patients […]
Surgery therapy for polypoidal choroidal vasculopathy
Authors: Jiao Mingfei, Li Xiaorong, Hu Bojie DOI: 10.3760/cma.j.cn115985-20200519-00354 Published 2020-07-10 Cite as Chin J Exp Ophthalmol, 2020,38(07): 629-632. Abstract [View PDF] [Read Full Text] With the development of intraocular injection of anti-vascular endothelial growth factor (VEGF) drugs, early treatment of polypoidal choroidal vasculopathy (PCV) has […]